Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here


Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

 
Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News


EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
Condition:   Heart Failure
Interventions:   Drug: Empagliflozin;   Drug: Placebo
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Not yet recruiting - verified February 2017

Thu, 16 Feb 2017 12:00:00 EST


EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
Condition:   Heart Failure
Interventions:   Drug: Empagliflozin;   Drug: Placebo
Sponsors:   Boehringer Ingelheim;   Eli Lilly and Company
Not yet recruiting - verified February 2017

Thu, 16 Feb 2017 12:00:00 EST


A Study of LY900014 Administered by an Insulin Pump in Type 1 Diabetes Participants
Condition:   Type1 Diabetes Mellitus
Interventions:   Drug: LY900014;   Drug: Insulin Lispro
Sponsor:   Eli Lilly and Company
Not yet recruiting - verified February 2017

Wed, 15 Feb 2017 12:00:00 EST


Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy Patients
Conditions:   Hepatitis C;   Hepatitis C, Chronic
Intervention:   Behavioral: Cognitive Behavior Coping Skills
Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified February 2017

Wed, 15 Feb 2017 12:00:00 EST


Resistant Starch, Gut Bacteria and Diabetes
Conditions:   Diabetes Mellitus, Type 2;   Pre Diabetes
Intervention:   Dietary Supplement: SymbioIntest
Sponsors:   University of Hohenheim;   Institut für Mikroökologie GmbH
Recruiting - verified February 2017

Wed, 15 Feb 2017 12:00:00 EST


The Influence of Needle-insertion Depth on Successful Epidurogram and Clinical Outcome in Caudal Epidural Injections
Condition:   Lumbosacral Radicular Pain
Intervention:   Procedure: new caudal injection technique
Sponsor:   Yonsei University
Not yet recruiting - verified February 2017

Wed, 15 Feb 2017 12:00:00 EST


Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients
Conditions:   Appointments and Schedules;   Diabetes Mellitus, Type 2
Intervention:   Other: Mobile phone text message reminder
Sponsors:   The University of Hong Kong;   Hospital Authority, Hong Kong
Recruiting - verified February 2017

Tue, 14 Feb 2017 12:00:00 EST


A Podiatry Led MDT Intervention to Reduce the Burden of Foot Disease in Patients With End Stage Kidney Failure
Conditions:   Diabetes Mellitus;   Endstage Renal Disease
Intervention:   Procedure: Podiatry
Sponsors:   South Tees Hospitals NHS Foundation Trust;   Boehringer Ingelheim
Not yet recruiting - verified February 2017

Mon, 13 Feb 2017 12:00:00 EST


Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study
Conditions:   Overactive Bladder;   Insulin Resistance
Intervention:  
Sponsor:   Duke University
Not yet recruiting - verified February 2017

Mon, 13 Feb 2017 12:00:00 EST


Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta 3-Adrenergic Receptor Agonists
Condition:   Healthy Volunteers
Interventions:   Drug: Mirabegron;   Other: B Complex Plus Vitamin C Tablets
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified February 6, 2017

Thu, 09 Feb 2017 12:00:00 EST


The Efficacy of Peer Support Model for Depression Care in Patients With Diabetes Mellitus
Conditions:   Diabetes Mellitus;   Depression
Intervention:   Behavioral: Peer support
Sponsor:   Makerere University
Not yet recruiting - verified February 2017

Thu, 09 Feb 2017 12:00:00 EST


Effects of Electromagnetic Therapy Versus Laser Therapy on Peripheral Diabetic Neuropathy
Condition:   Diabetes
Interventions:   Device: Magnetic therapy;   Device: laser therapy;   Drug: Only medical treatment
Sponsor:   Dammam University
Completed - verified February 2017

Wed, 08 Feb 2017 12:00:00 EST


Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus
Conditions:   Type 2 Diabetes Mellitus;   Insulin Resistance
Interventions:   Drug: Mifepristone 600 mg daily;   Drug: Placebo
Sponsor:   Charles Drew University of Medicine and Science
Recruiting - verified February 2017

Wed, 08 Feb 2017 12:00:00 EST


Red Raspberry Polyphenols on Gut Microbiome
Conditions:   Healthy Subjects;   Pre-diabetes
Interventions:   Dietary Supplement: Raspberry and fructooligosaccharide;   Dietary Supplement: Raspberry
Sponsor:   Institute for Food Safety and Health, United States
Not yet recruiting - verified February 2017

Wed, 08 Feb 2017 12:00:00 EST


Whole Milk Compared With Skimmed Milk and Effect on Lipids
Condition:   Atherosclerosis
Intervention:   Other: Milk type
Sponsor:   University of Copenhagen
Completed - verified February 2017

Wed, 08 Feb 2017 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


FDA approves new psoriasis drug
The U.S. Food and Drug Administration today approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.

Wed, 15 Feb 2017 17:47:00 -0500


FDA approves drug to treat Duchenne muscular dystrophy
The U.S. Food and Drug Administration today approved Emflaza (deflazacort) tablets and oral suspension to treat patients age 5 years and older with Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness. Emflaza is a corticosteroid that works by decreasing inflammation and reducing the activity of the immune system.

Thu, 09 Feb 2017 14:05:00 -0500


Federal judge approves consent decree with California dietary supplement distributor, Regeneca Worldwide
A California dietary supplement distributor has been ordered by a federal court to stop selling its products, which were found to contain unsafe ingredients including 1, 3-dimethylamylamine (DMAA).

Thu, 09 Feb 2017 10:47:00 -0500


FDA permits marketing of first newborn screening system for detection of four, rare metabolic disorders
FDA permits marketing of first newborn screening system for detection of four, rare metabolic disorders

Fri, 03 Feb 2017 16:32:00 -0500


FDA confirms elevated levels of belladonna in certain homeopathic teething products
The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency is warning consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products.

Fri, 27 Jan 2017 13:40:00 -0500


FDA approves Trulance for Chronic Idiopathic Constipation
The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.

Thu, 19 Jan 2017 16:04:00 -0500


Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch
Today the U.S. Food and Drug Administration is establishing the Oncology Center of Excellence (OCE) and appointing Dr. Richard Pazdur as its director. This will make oncology the first disease area to have a coordinated clinical review of drugs, biologics and devices across the agency’s three medical product centers.

Thu, 19 Jan 2017 09:03:00 -0500


Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical product communications
We recognize that there is a high level of interest regarding FDA’s views on communications about medical products. We are committed to an ongoing dialogue with industry and other stakeholders, and, when needed, providing guidance to clarify the agency’s thinking on these issues. Today, the FDA released two separate draft guidances that will each help provide clarity for medical product companies, as well as other interested parties, on FDA’s current thinking and recommendations for a few different types of communications about medical products.

Wed, 18 Jan 2017 09:24:00 -0500


FDA and EPA issue final fish consumption advice
Today, the U.S. Food and Drug Administration and the U.S. Environmental Protection Agency issued final advice regarding fish consumption. This advice is geared toward helping women who are pregnant or may become pregnant – as well as breastfeeding mothers and parents of young children – make informed choices when it comes to fish that are healthy and safe to eat. (This advice refers to fish and shellfish collectively as “fish.”)

Wed, 18 Jan 2017 09:04:00 -0500


FDA approves first drug for spinal muscular atrophy
The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children and adults with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement. Spinraza is an injection administered into the fluid surrounding the spinal cord.

Fri, 23 Dec 2016 16:39:00 -0500
Diabetes news from the American Diabetes Association

Latest Top (5) News